Skip Page Header

Home > Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone).

European Monitoring Centre for Drugs and Drug Addiction. (2010) Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

[img]
Preview
PDF - Published Version
193kB

On 15 July 2010, the EMCDDA extended Scientific Committee, with the participation of additional experts from the EU Member States, European Commission, Europol and the European Medicines Agency, undertook a formal risk assessment on the synthetic drug mephedrone (4-methylmethcathinone).

This constituted the second phase in the three-step legal procedure established to monitor and respond to new psychoactive substances in Europe (information exchange/early-warning; risk assessment; decision-making).

The risk-assessment report is now submitted to the Commission and Council of the EU in the final stage of the process. On the basis of the report, the Council, upon an initiative of the Commission, may decide to subject mephedrone to control measures throughout the EU.


Item Type
Report
Publication Type
International, Guideline
Drug Type
New psychoactive substance
Intervention Type
Screening / Assessment
Date
2010
Pages
16 p.
Publisher
European Monitoring Centre for Drugs and Drug Addiction
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote

Repository Staff Only: item control page